Inactive Instrument

Golden Meditech Holdings Limited Stock

Equities

801

KYG395801247

Medical Equipment, Supplies & Distribution

Dynamic Chart
Golden Meditech Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2020 CI
Golden Meditech Holdings Limited Reports Earnings Results for the Six Months Ended September 30, 2019 CI
Golden Meditech Holdings Limited(SEHK:801) dropped from S&P Global BMI Index CI
Golden Meditech Holdings Limited Reports Earnings Result for the Year Ended March 31, 2019 CI
Golden Meditech Holdings Limited Provides Unaudited Earnings Guidance for the Year Ended March 31, 2019 CI
Golden Meditech Holdings Limited Announces Management Changes CI
Golden Meditech Holdings Limited and Hong Kong Baptist University Team Up to Conduct Cell Therapy Research CI
Golden Meditech Holdings Limited Announces Earnings Results for the Six Months Ended September 30, 2018 CI
Golden Meditech Holdings Limited Announces Group Earnings Results for the Year Ended March 31, 2018 CI
Golden Meditech Holdings Limited Provides Earnings Guidance for the Year Ended 31 March 2018 CI
Golden Meditech Holdings Limited Announces Board Changes CI
Golden Meditech Holdings Limited Declares Special Dividend, Payable on or around 26 March 2018 CI
Tranche Update on Golden Meditech Holdings Limited's Equity Buyback Plan announced on October 30, 2017. CI
Golden Meditech Holdings Limited‘s Equity Buyback announced on October 30, 2017, has expired with 49,207,566 shares, representing 1.66% for TWD 218.97 million CI
Golden Meditech And Permira Leave Race For I-MED CI
More news
Managers TitleAgeSince
Chief Executive Officer 54 14-12-31
Corporate Secretary 40 19-05-23
Corporate Officer/Principal 50 -
Members of the board TitleAgeSince
Chief Executive Officer 54 14-12-31
Chief Executive Officer 62 01-09-02
Chairman 55 -
More insiders
Golden Meditech Holdings Limited is a Hong Kong-based investment holding company principally engaged in medical businesses. The Company operates through four segments. Medical Devices segment is engaged in the development, manufacture and sales of medical devices and medical accessories. Hospital Management segment is engaged in the provision of hospital management services and hospital operation in China. Its hospitals include Beijing Qinghe Hospital and Shanghai East International Medical Center. Medical Insurance Administration segment is engaged in the provision of medical insurance administration services in China. Chinese Herbal Medicines segment is engaged in the research and development, manufacture and sales of Chinese herbal medicines.
More about the company